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Cosinor modelling of seasonal variation in 25-hydroxyvitamin
D concentrations in cardiovascular patients in Norway
E Degerud1, R Hoff2, O Nygård3,4, E Strand3, DW Nilsen3,5, JE Nordrehaug3,4, Ø Midttun6, PM Ueland3,7, S de Vogel8 and J Dierkes1
BACKGROUND/OBJECTIVES: Seasonal variation may reduce the validity of 25-hydroxyvitamin D (25OHD) as a biomarker of vitamin
D status. Here we aimed to identify potential determinants of seasonal variation in 25OHD concentrations and to evaluate cosinor
modelling as a method to adjust single 25OHD measurements for seasonal variation.
SUBJECTS/METHODS: In Caucasian cardiovascular patients (1999–2004), we measured 25OHD by liquid chromatography tandem
mass spectrometry in 4116 baseline and 528 follow-up samples. To baseline values, we fitted a cosinor model for monthly
concentrations of 25OHD. Using the model, we estimated each patient’s adjusted annual 25OHD value. Further, we studied how
covariates affected the annual mean 25OHD concentration and seasonal variation of the study cohort. To evaluate the model, we
predicted follow-up measurements with and without covariates and compared accuracy with carrying forward baseline values and
linear regression adjusting for season, common approaches in research and clinical practice, respectively.
RESULTS: The annual mean (59.6 nmol/l) was associated with participants’ age, gender, smoking status, body mass, physical activity
level, diabetes diagnosis, vitamin D supplement use and study site (adjusted models, Po0.05). Seasonal 25OHD variation was
15.8 nmol/l, and older age (462 years) was associated with less variation (adjusted model, P= 0.025). Prediction of follow-up
measurements was more accurate with the cosinor model compared with the other approaches (Po0.05). Adding covariates to
cosinor models did not improve prediction (P40.05).
CONCLUSIONS: We find cosinor models suitable and flexible for analysing and adjusting for seasonal variation in 25OHD
concentrations, which is influenced by age.
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INTRODUCTION
In countries located increasingly distant from the Earth’s equator,
the population concentration of 25-hydroxyvitamin D (25OHD)
tends to follow changes in the ultraviolet B radiation from the
sun.1–6 The use of a single measurement of 25OHD to assess
vitamin D status and categorise individuals according to vitamin D
status may introduce a systematic bias and should be accounted
for when analysing the relationship between 25OHD concentra-
tions and a specific outcome. An alternative is to adjust the
relationship between 25OHD concentrations and the outcome for
season by including season as a covariate in inferential statistical
analysis. Another to adjust the measured 25OHD values for
seasonality before descriptive analyses, resulting in a season-
specific quartile7,8 or a unique value for each person. Unique
values can be obtained with different approaches, including
simple computation9 or modelling.10,11 An example of a
computation is adding to each participant’s measured value, the
mean difference between the study sample and the participants
with blood measurements taken in the same month as that of the
individual.9 An example of a modelling approach is the use of a
cosinor model, which assumes that the seasonal variation follows
a sinusoidal pattern.11 However, the degree of seasonal variation
may be influenced by other factors, such as pigmentation of the
skin, age, gender and body mass. Among the methods mentioned
above, the cosinor model is the only one that allows identification
of and adjustment for potential determinants of seasonal variation
in 25OHD concentration. Cosinor models may increase the
accuracy of the assessment of vitamin D status in observational
studies. It may also help clinicians identify patients at risk of
developing vitamin D insufficiency across seasons.
The purpose of this study was to use cosinor models to identify
potential determinants of seasonal variation in 25OHD concentra-
tions and to evaluate the model as an approach to adjust single
measurements of 25OHD for seasonal variation. Previous evalua-
tions of the model as an approach to adjust for seasonal variation
were conducted in New Zealand10 and North America,11 and we
aimed to contribute with data from Europe. We used baseline
measurements of 25OHD from 4116 cardiovascular patients and
follow-up measurements from 271 nested patients.
SUBJECTS AND METHODS
The Bergen Coronary Angiography Cohort (BECAC) included patients who
underwent elective coronary angiography at Haukeland University
Hospital, Bergen, Norway (60° North), between January 1999 and April
2004. Patients who agreed to participate in BECAC were also asked to
participate in Western Norway B-Vitamin Intervention Trial (WENBIT), a
two-centre randomised controlled trial.12 The second WENBIT centre was
Stavanger University Hospital, Stavanger, Norway (59° North). From the
overlapping samples in WENBIT and BECAC, we included patients
(n=4116) with suspected or verified stable angina pectoris and available
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25OHD concentrations from baseline plasma samples. A flow chart is
provided (Supplementary Figure 1).
One or two follow-up measurements of 25OHD, in total 528, were
available from 271 WENBIT patients who also participated in a nested
substudy.13 The substudy aimed to study progression of coronary artery
disease and only recruited WENBIT participants enrolled at Haukeland
University Hospital with coronary artery disease verified by the first
angiography. Follow-up measurements were collected at two substudy
exams ~ 1 month and 1 year after baseline. The studies were conducted
according to the principles of the Declaration of Helsinki and approved by
the Regional Committee for Medical and Health Research Ethics and the
Norwegian Data Inspectorate. All participants gave broad written consent
for the use of the collected data in future research.
Blood sampling and measurement of 25OHD
Blood samples were collected between 1999 and 2005 by study personnel
and stored at − 80 °C. Plasma concentrations of 25OHD2 and 25OHD3 were
analysed between 2011 and 2012 using liquid chromatography tandem
mass spectrometry at Bevital AS (www.bevital.no), which is certified by the
Vitamin D External Quality Assessment Scheme (www.deqas.org).14 25OHD
is stable during long-term storage in plasma samples and after repeated
freeze and thawing cycles.15 Measurements below the lower limit of
quantification (6.6 nmol/l) were excluded for both 25OHD3 (n= 1) and
25OHD2 (n= 4037 and n= 268 at both follow-up exams). One participant
with very high 25OHD2 was excluded. The concentrations of 25OHD2 and
25OHD3 were summed to reflect total 25OHD concentration.
Covariates
Anthropometry and blood pressure measurements were performed by
study personnel. Smoking was defined as a self-reported smoker or stopped
smoking ⩽ 90 days ago or a plasma cotinine concentration 485 nmol/l
(~15 ng/ml).16 Plasma cotinine was measured by liquid chromatography
tandem mass spectrometry at Bevital AS.17 Data on supplement consump-
tion and physical activity level were based on self-report. Diabetes mellitus
was defined as a pre-existing diagnosis of either type I or II. Hypertension
was defined by systolic blood pressure 4140mmHg and/or diastolic blood
pressure 490mmHg and/or the use of antihypertensive drug. Hypercho-
lesterolaemia was defined as familial hypercholesterolaemia or untreated
total serum cholesterol ⩾ 6.5mmol/l = 251.4mg/dl. The estimated glomer-
ular filtration rate was calculated using the formula suggested by the
Chronic Kidney Disease Epidemiology Collaboration.18 Serum concentrations
of apolipoprotein A-1 and apolipoprotein B were analysed with the Hitachi
917 system (Roche Diagnostics GmbH, Mannheim, Germany). The measure-
ment of serum C-reactive protein was performed with a latex, high-
sensitivity assay (Behring Diagnostics, Marburg, Germany). The angiographic
extent of coronary artery disease was assessed by trained cardiologists. This
variable is described as the aggregated number of stenotic blood vessels
(⩾50% luminal narrowing). To reflect months during which sun exposure
results in significant or negligible synthesis of vitamin D, we defined the four
seasons of blood draw as January–March, April–June, July–September and
October–December. The dark (October–March) and bright (April–Septem-
ber) periods were defined based on the same reasoning.
Statistical analysis
To analyse the seasonal variation of 25OHD concentrations, we fitted
cosinor models to baseline measurements, choosing month of measure-
ment to represent time. The cosinor model consists of fitting a linear
regression where the 25OHD measurements are regressed onto a sine and
a cosine term of transformations of the time variable.19 Taken together, the
terms give a linear representation of a sine curve with amplitude and a
phase, which can be used to describe a seasonal pattern. From the
regression output, the coefficient for the intercept is the mean level of the
sine curve and thus an estimate of the annual mean 25OHD concentration
of the study sample. Confidence intervals for the intercept were calculated
directly from the regression output. The amplitude, which is defined as the
distance from the mean to the highest (peak) or lowest (trough) location of
the curve, provides an estimate of seasonal variation. The phase is the
location of the peak on the x axis, equivalent to the month where the
25OHD concentration is highest. Because of symmetry the trough will be
6 months apart from the peak. Both amplitude and phase can be
calculated from the regression coefficients for the sine and cosine term.19
Standard errors and corresponding confidence intervals are calculated
with the Delta method. The distance from the highest to the lowest point
of the sine curve (peak-trough), equivalent to twice the amplitude, is an
estimate of average total seasonal variation.
To investigate associations of the annual mean 25OHD concentration
with patient characteristics, we included covariates in the model. Including
a covariate does not alter the shape of the curve but rather shifts it up or
down. We used simple and multivariate Wald tests directly on regression
coefficients of interest to test whether any differences in annual mean
were due to chance. To investigate whether seasonal variation differs
according to patient characteristics, we added interaction terms between
covariates and the sine and cosine terms, as both the amplitude and the
phase of the sine curve can change according to covariate values. Simple
and multivariate Wald tests were performed using estimated amplitudes
and standard errors calculated with the Delta method. Covariate
association with both annual mean and amplitude of 25OHD was
investigated for gender, age, study site, smoking, body mass index,
physical activity, estimated glomerular filtration rate, C-reactive protein,
vitamin D supplement use and a diagnosis of diabetes mellitus. We first
investigated each covariate in an unadjusted model without other
covariates and then in a model adjusted for age, gender, study site, body
mass index and smoking. Covariates in adjusted models were selected
because of their relationship with the mean annual 25OHD or the seasonal
variation of 25OHD in unadjusted models, provided covariate data were
available for most participants.
We evaluated the cosinor model fitted to the 4116 baseline measure-
ments by assessing how accurately the model predicted follow-up
measurements from a nested subgroup of 271 participants who attended
either one or two follow-up exams. For each patient, we predicted the
25OHD concentration at the months of follow-up by calculating patient-
specific sine curves from the cosinor model. The height of the curve was
set to match the patient's observed value at baseline. The shape of the
curve was determined by the patient's covariate values. Predicted values
for different months could then be derived from the curve. The predictive
performance was assessed by calculating squared errors, where the errors
are defined as the difference between predicted values and measured
values at follow-up. We compared the predictions of a cosinor model with
carrying baseline values forward and predictions of a linear regression
adjusting for the season of blood draw. We also investigated whether
adding covariates to the cosinor model improved prediction. Comparisons
were carried out with paired t-tests applied to the mean squared errors.
To adjust measured 25OHD values for seasonal variation, we added
individual deviations from the fitted sine curve to the annual mean of the
study sample, thereby calculating an annual value for each participant. If
we impose a threshold in 25OHD concentration for what is considered
sufficient or insufficient, participants may be classified differently depend-
ing on whether the annual or the measured value is used. Participants
were categorised as either vitamin D sufficient (⩾50 nmol/l) or insufficient
(o50 nmol/l) using both measured values and annual values estimated
from cosinor models with and without covariates and linear regression
adjusting for season of blood draw. We then calculated the number and
proportion of participants who were reclassified. The agreement was
assessed considering the year as a whole and within the dark and bright
period separately.
P-values are two-sided and the level of significance set at a value of
Po0.05. We did not adjust for multiple comparisons. All statistical analyses
were performed in R (version 3.1.1)20 using the packages season21 (version
0.3–4) and cosinor (version 1.1).
RESULTS
Table 1 shows descriptive statistics at baseline of all participants
(n= 4116) and a subgroup (n= 271) with available follow-up
measurements of 25OHD from participation in a nested substudy.
Because of substudy inclusion criteria nested participants differed
from the study cohort for the extent of coronary artery disease,
statin treatment coverage and study site, which in turn may
have resulted in a difference in measured 25OHD concentration
(66 versus 59 nmol/l, Po0.001).
Figure 1 shows the measured 25OHD concentrations at baseline
according to the month of blood sampling. The months with
lowest and highest measured mean concentration were March
(51.7 ± 18.5 nmol/l) and August (70.4 ± 20.3 nmol/l), respectively.
A fitted line from an unadjusted cosinor model is overlaid on the
measured values. The annual mean 25OHD concentration derived
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from the model was 59.6 nmol/l, with a trough occurring between
January and February and a peak between July and August. Total
difference in annual mean 25OHD concentration from peak to
trough was 15.8 nmol/l (amplitude: 7.9 nmol/l), equivalent to
26.5% of annual mean. Assuming that the estimated seasonal
variation is true for all participants, a concentration of 65.8 nmol/l
would thus be required in August to remain vitamin D sufficient
(450 nmol/l) in February.
The associations between covariates and mean annual con-
centration of 25OHD and seasonal variation are presented in
Table 2. In both unadjusted and adjusted analyses, older age (462
years), higher physical activity levels and regular consumption of
vitamin D supplements were associated with a higher annual
mean 25OHD concentration. A lower annual mean was associated
with female gender, study site, smoking, adiposity and having a
diagnosis of diabetes mellitus. The mean difference (95%
confidence interval) in annual mean 25OHD between obese and
normal weight participants was − 6.4 (−8.4, − 4.5) nmol/l in a
sensitivity analysis (n= 3027), which further adjusted for vitamin D
supplement consumption and physical activity.
In unadjusted analyses, smoking was associated with more
seasonal variation in 25OHD concentration, whereas female
gender, older age and a regular consumption of vitamin D
supplements were associated with less seasonal variation
(Table 2). In adjusted analyses, only the association with age
remained statistically significant. The mean peak-trough 25OHD
concentration was 19 nmol/l for participants below 62 years of age
and 12.3 nmol/l for participants above 62 years of age. To remain
vitamin D sufficient (450 nmol/l) at the time of the seasonal
trough, a concentration of 69 and 62.3 nmol/l would thus be
required during the peak for participants below and above 62
years of age, respectively.
Time from baseline to the first and second follow-up measure-
ment varied between participants (Supplementary Table 1).
Predictions of 25OHD concentrations at the time of follow-up
measurements from an unadjusted cosinor model were more
accurate than carrying forward baseline values and compared
Table 1. Baseline characteristics of the study sample and nested subgroup
Variable All participants (n= 4116) Nested participants with follow-up measurements (n= 271)
25-Hydroxyvitamin D level (nmol/l) 59.4± 20.3 65.9± 21.4
Age (years) 61.8± 10.4 60.8± 10.2
Male sex, n (%) 2960 (71.9) 218 (80.4)
Study site, n (%)
Bergen 3369 (81.9) 271 (100)
Stavanger 747 (18.1) —
Smoking, n (%) 1301 (31.7) 82 (30.3)
Body mass index (kg/m2) 26.8± 4.0 26.9± 3.4
C-reactive protein ⩾ 10mg/l, n (%) 278 (6.8) 13 (4.8)
Physical activity ⩾ 2 h per week, n (%) 2135 (68.8) 185 (70.3)
Vitamin D supplements regularly or daily, n (%) 1191 (33.6) 98 (37.5)
Diabetes mellitus type 1 or 2, n (%) 491 (11.9) 29 (10.7)
Hypertension, n (%) 1928 (46.8) 121 (44.6)
Systolic blood pressure, mmHg 141± 20.8 142± 21.6
Estimated glomerular filtration rate, ml/min per 1.732 87.8± 17.2 90.9± 14.6
Hypercholesterolaemia, n (%) 2228 (57.9) 162 (62.8)
Statin therapy, n (%) 2982 (72.4) 226 (83.4)
Extent of coronary artery disease
No stenotic vessels 1035 (25.1) —
One vessel 952 (23.1) 137 (50.6)
⩾ Two vessels 2129 (51.7) 134 (49.4)
Continuous variables are presented as mean± s.d. and categorical variables as numbers (n) and percentages (%). Missing values: smoking (n= 7), BMI (n= 3),
systolic blood pressure (n= 12), hypercholesterolaemia (n= 267), physical activity level (n= 1015), C-reactive protein (n= 1), estimated glomerular filtration rate
(n= 3) and vitamin D supplement use (n= 523). Abbreviation: BMI, body mass index.




















Figure 1. Seasonality of 25OHD concentrations in 4116 participants
at baseline. Boxplots show median 25OHD concentration as dark
horizontal lines, hinges encompass the 25th and 75th percentiles,
whiskers either show maximum value or 1.5 times the interquartile
range, and values beyond are plotted as points. The y axis is
truncated at 155 nmol/l. The overlaid curve is from an unadjusted
cosinor model and shows the annual mean 25OHD concentration
according to month of the year.
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with predictions from a linear regression model adjusted for
season of blood draw (Po0.05; Table 3). The proportion of
predictions that differed o10 nmol/l from measured values was
59% with an unadjusted cosinor model, 55% when carrying
forward baseline values and 54% with the linear model adjusting
for season. Because of the association of age with seasonal
variation in 25OHD concentrations in the adjusted model, we
assessed whether adding age to a cosinor model would change
the accuracy of predictions. We also investigated the accuracy of a
multivariate model with covariates associated with seasonal
variation in univariate models (age, gender, smoking and vitamin
D supplement consumption). No difference in predictive accuracy
was observed between the simple cosinor model and cosinor
models with covariates.
Table 4 shows participants categorised as vitamin D sufficient or
insufficient according to measured 25OHD and annual 25OHD
values from an unadjusted cosinor model and reclassification
across this threshold of 50 nmol/l. Overall, 10.4% of participants
were reclassified across the threshold. Reclassification of a cosinor
model adjusted for age (10.6%), multivariate cosinor model
(10.8%) and linear regression with dummy variables for season
(7.8%) are presented separately (Supplementary Table 2).
DISCUSSION
Our study found several patient characteristics that associated
with the mean annual 25OHD concentration of the study sample.
The characteristic that most strongly associated with a higher
concentration was regular consumption of vitamin D supple-
ments, which was predominantly (94%) in the form of cod liver oil
(~10 μg vitamin D3 per teaspoon, 5 ml). The characteristic that
most strongly associated with a lower concentration was
adiposity, which is an established relationship22 that may reflect
retention of vitamin D in adipose tissue,23 extracellular pool size,24
lifestyle factors or a combination. The amount of vitamin D
required to reach a target concentration of 25OHD in clinical trials
is proportional to the increase in body weight.25 Hence, a person
of 100 kg requires twice as much vitamin D as a person of 50 kg to
sustain the same 25OHD concentration. A more comprehensive
adjustment for lifestyle did only slightly attenuate this association.
Seasonal 25OHD variation was lower in participants of older age
(⩾62 years), potentially reflecting age-dependent reductions in the
capacity to synthesis vitamin D from ultraviolet B exposure.26,27
Some10,11 but not all4 studies using cosinor modelling to assess
this association reported similar findings, and a reverse association
was observed in younger populations.6 We hypothesise that
retirement provides opportunity for sun exposure during a longer
period of the year, for example, by an increase in recreational
physical activity,28 and thereby reduces the compulsion for
exaggerated and compensatory sun exposure during the summer.
Such behaviours may also explain why we observe that older
participants have slightly higher and more stable vitamin D status
throughout the year than younger participants.
Cosinor modelling has to our knowledge been evaluated
previously in two multiethnic cohorts of patients in New Zealand10
(37°S) and community-living subjects in North America11 (~34 to
~45°N), as a method to adjust 25OHD concentration for seasonal
variation and predict future concentrations. The current study
provides data from a North European (59–60°N) cohort of Caucasian
patients. We observed that predictions from an unadjusted cosinor
model corresponded more accurately to follow-up values than if we
carried forward baseline values or predicted from linear regression
adjusting for season. Similar findings were observed in North
America, whereas the study from New Zealand did not compare with
other approaches. Using the unadjusted cosinor model, the
percentage of predictions within ±10 nmol/l (4 ng/ml) of follow-up
values was 59% in our cohort, similar to 57% in North America,11 and
somewhat less accurate than in New Zealand (74%).10 In the North
American study, age was associated with seasonal variation, but age-
specific sine curves did not result in a more accurate prediction of
future vitamin D status nor did any other covariate-specific
adjustments. Hence, a crude model without additional covariates
seems to be adequate when adjusting for seasonal variation in
different populations, continents and latitudes.
Table 3. Accuracy of methods in predicting 528 follow-up measurements of 25-hydroxyvitamin D from 271 participants
Methoda Correlation (95% CI)b MSE RMSE S.d. Method comparisonc P-value
Cosinor
Unadjusted 0.77 (0.74, 0.81) 198 14.1 21.4 Ref.
Plus age 0.77 (0.73, 0.80) 199 14.1 21.4 0.427
Multivariate 0.77 (0.73, 0.80) 201 14.2 21.4 0.331
Baseline value carried forward 0.75 (0.71, 0.78) 221 14.8 21.4 0.001
Linear regression adjusted for season 0.71 (0.67, 0.75) 246 15.7 21.2 o0.001
Abbreviations: CI, confidence interval; MSE, mean squared error; RMSE, root mean squared error. MSE is the difference between predicted and measured
values squared; RMSE is the square root of mean squared errors; s.d. of predicted values. aMissing values (n): linear regression (n= 2), cosinor unadjusted
(n= 2), plus age (n= 2), multivariate model with age, gender, smoking and vitamin D supplement consumption (n= 6). bPearson’s product-moment correlation
coefficient with 95% CI of predicted or baseline values with measured values at follow-up. cDifferences in predictive accuracy of methods were tested with
paired t-tests on squared errors.
Table 4. Classification of subjects according to vitamin D statusa
Measured 25OHD
concentration
Annual 25OHD concentration Reclassified
⩾ 50 nmol/l o50 nmol/l
All year (n= 4116) n n %
⩾ 50 nmol/l 2531 183 6.7
o50 nmol/l 246 1156 17.5
Total 10.4
Dark period (n = 2214)
⩾ 50 nmol/l 1271 38 2.9
o50 nmol/l 214 691 23.6
Total 11.4
Bright period (n = 1902)
⩾50 nmol/l 1260 145 10.3
o50 nmol/l 32 465 6.4
Total 9.3
Abbreviation: 25OHD, sum of 25-hydroxyvitamin D2 and D3. Dark and
bright periods were defined as months of negligible or significant vitamin
D synthesis from sun exposure, respectively. Dark period ranges from
October to March and bright period from April to September. aObtained
from measured concentrations of 25OHD (nmol/l) and annual concentra-
tions derived from an unadjusted cosinor model.
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Baseline values did more accurately correspond to follow-up
values than predictions from a linear model adjusting for season,
in contrast to findings in the North American study.11 We believe
that this difference could reflect the time interval between
repeated measurements. In our study, the first follow-up
measurement occurred within 1 month following the baseline
month for 66% of the 271 participants. In terms of prediction, the
close proximity may have favoured carrying forward baseline
values, as 25OHD concentrations from over a short time period are
likely to correlate. The North American study had repeated
measurements more equally spaced throughout the year, which
could be to the advantage of the linear regression model. There
are other modelling approaches that could be modified for
analysis of seasonal variation. However, our aim was not to
identify the optimal approach by assessing all possibilities but to
evaluate the suitability of the cosinor model in comparison with
common approaches in epidemiology and clinical practice.
The proportion of participants classified as vitamin D insufficient
was 34.1% according to measured values and 32.5% according to
annual values from an unadjusted cosinor model. In comparison
with New Zealand10 (48% and 63%, respectively), this change was
moderate. However, the proportion reclassified across the thresh-
old of sufficiency was 10.4% (n= 429), which is higher than 7.1%
reclassification in North America.11 The impact of adjusting for
seasonality was more pronounced with cosinor models than with
linear regression with dummy variables for season (7.8%). We also
consider these adjustments to be more reliable, if we regard
performance in predicting future vitamin D status as an indirect
measurement of accuracy in the adjusted values.
Cosinor modelling provides a flexible framework for analysing
and adjusting for seasonality of 25OHD. It compares favourable in
terms of predictive performance to linear regression with dummy
variables for season and to simply carry forward baseline values,
which are common approaches in epidemiology and clinical
practice, respectively. Age was a determinant of seasonal variation
in 25OHD but did not enhance prediction of future vitamin D
status in comparison with a simple cosinor model.
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